Encapsulation of zinc-rifampicin complex into transferrin-conjugated silver quantum-dots improves its antimycobacterial activity and stability and facilitates drug delivery into macrophages

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Pati, Rashmirekha ^a   Sahu, Rojalin ^a   Panda, Jagannath ^a   Sonawane, Avinash ^a  

^a KIIT UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; QUANTUM DOT; RIFAMPICIN; SILVER; TRANSFERRIN; TUBERCULOSTATIC AGENT; ZINC;

A-549 CELL LINE; ANIMAL; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENDOCYTOSIS; FLUORESCENCE MICROSCOPY; HUMAN; INFRARED SPECTROSCOPY; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; X RAY PHOTOELECTRON SPECTROSCOPY;

A549 CELLS; ANIMALS; ANTITUBERCULAR AGENTS; CELL SURVIVAL; DRUG CARRIERS; ENDOCYTOSIS; HUMANS; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICROSCOPY, FLUORESCENCE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; PARTICLE SIZE; PHOTOELECTRON SPECTROSCOPY; QUANTUM DOTS; RIFAMPIN; SILVER; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TRANSFERRIN; ZINC;

EID: 84964681193     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24184     Document Type: Article

References (46)

1. Sandhu, G. K. Tuberculosis: current situation, challenges and overview of its control programs in India. J Glob Infect Dis. 3, 143-50 (2011).
2. Brigden, G., Hewison, C. & Varaine, F. New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid. Infect Drug Resist. 8, 367-78 (2015).
3. Lawn, S. D. & Wilkinson, R. Extensively drug resistant tuberculosis. BMJ. 333, 559-60 (2006).
4. Hart, P. D., Young, M. R., Gordon, A. H. & Sullivan, K. H. Inhibition of phagosome-lysosomefusion in macrophages by certain mycobacteria can be explained by inhibition oflysosomal movements observed after phagocytosis. J Exp Med. 166, 933-46 (1987).
5. Simeone, R. et al. Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. PLoS Pathog. 8, e1002507 (2012).
6. Rohde, K., Yates, R. M., Purdy, G. E. & Russell, D. G. Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev. 219, 37-54 (2007).
7. Ganguly, N. et al. Mycobacterium tuberculosis secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide-induced NF-kappaB transactivation by downregulation of reactive oxidative species (ROS) production. Immunol Cell Biol. 86, 98-106 (2008).
8. Pershina, A. G. et al. Study of DNA interaction with cobalt ferrite nanoparticles. J Nanosci Nanotechnol. 11, 2673-7 (2011).
9. Patel, M. N., Patel, C. R. & Joshi, H. N. Metal-based biologically active compounds: synthesis, characterization, DNA interaction, antibacterial, cytotoxic and SOD mimic activities. Appl Biochem Biotechnol. 169, 1329-45 (2013).
10. Chohan, Z. H., Pervez, H., Rauf, A., Khan, K. M. & Supuran, C. T. Isatin-derived antibacterialand antifungal compounds and their transition metal complexes. J Enzyme Inhib MedChem. 19, 417-23 (2004).
11. Hubin, T. J. et al. Synthesis and antimalarial activity of metal complexes of cross-bridged tetraazamacrocyclic ligands. Bioorg Med Chem. 22, 3239-44 (2014).
12. Khan, S. A., Asiri, A. M., Al-Amry, K. & Malik, M. A. Synthesis, characterization, electrochemical studies, and in vitro antibacterial activity of novel thiosemicarbazone and its Cu(II), Ni(II), and Co(II) complexes. Scientific World Journal 2014, 592375 (2014).
13. Gülbay, B. E. et al. Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis. Respir Med. 100, 1834-42 (2006).
14. Patel, M. N., Dosi, P. A. & Bhatt, B. S. Synthesis, characterization and biological activities of ciprofloxacin drug based metal complexes. Acta Chim Slov. 59, 622-31 (2012).
15. Xie, Y., He, Y., Irwin, P. L., Jin, T. & Shi, X. Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni. Appl Environ Microbiol. 77, 2325-31 (2011).
16. Pati, R. et al. Topical application of zinc oxide nanoparticles reduces bacterial skin infection in mice and exhibits antibacterial activity by inducing oxidative stress response and cell membrane disintegration in macrophages. Nanomedicine 6, 1195-208 (2014).
17. Fukuda, R. & Nagasawa-Fujimori, H. Mechanism of the rifampicin induction of RNA polymerase beta and beta' subunit synthesis in Escherichia coli. J Biol Chem. 25, 2720-8 (1983).
18. Grosset, J. & Leventis, S. Adverse effects of rifampin. Rev Infect Dis. 5, 440-50 (1983).
19. Gaude, G. S., Chaudhury, A. & Hattiholi, J. Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients. J Family Med Prim Care 4, 238-43 (2015).
20. Michalet, X. et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538-44 (2005).
21. Medintz, I. L., Uyeda, H. T., Goldman, E. R. & Mattoussi, H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater. 4, 435-46 (2005).
22. Alivisatos, P. The use of nanocrystals in biological detection. Nat Biotechnol. 22, 47-52 (2004).
23. Smith, A. M., Dave, S., Nie, S., True, L. & Gao, X. Multicolor quantum dots for molecular diagnostics of cancer. Expert Rev Mol Diagn. 6, 231-44 (2006).
24. Langerholm, B. C. et al. Multicolor coding of cells with cationic Peptide coated quantum dots. Nano Letters. 4, 2019-2022 (2004).
25. Anas, A. et al. Clathrin-mediated endocytosis of quantum dot-peptide conjugates in living cells. ACS Nano 3, 2419-29 (2009).
26. Ibiapino, A. L., Seiceira, R. C. Jr., P. A., Trindade, A. C. & Ferreira, F. F. Structural characterization of form I of anhydrous rifampicin. Cryst Eng Comm. 16, 8555-8562 (2014).
27. Majumder, A., Rosair, G. M., Mallick, A., Chattopadhyay, N. & Mitra, S. Synthesis, structures and fluorescence of nickel, zinc and cadmium complexes with the N,N,O-tridentate Schiff base N-2-pyridylmethylidene-2-hydroxy-phenylamine. Polyhedron 25, 81753-1762 (2006).
28. Gallis, D. F., Rohwer, L. E. S., Rodriguez, M. A. & Tina, M. N. Efficient photoluminescence via metal-ligand alteration in a new MOFs family. Chem. Mater. 26, 2943-2951 (2014).
29. Sheridan, U., Gallagher, J. F., Philippidis, A. & McGinley, J. Zinc complexes of pyridyl-tetrazole derivatives - Highly fluorescent materials. Inorganica Chimica Acta. 432, 50-55 (2015).
30. Zou, C. et al. Facile synthesis of Cu2ZnSnS4 nanocrystals. Cryst Eng Comm. 13, 3310-3313 (2011).
31. Lacerda, L., Parize, A. L., Fávere, V., Laranjeira, M. C. & Stulzer, H. K. Development and evaluation of pH-sensitive sodium alginate/ chitosan microparticles containing the antituberculosis drug rifampicin. Mater Sci Eng C Mater Biol Appl. 39, 161-7 (2014).
32. Li, C. et al. Ulrich. Blue transition metal complexes of a natural bilin-type chlorophyll catabolite. Chem. Sci. 5, 3388-3395 (2014).
33. Pieters, J. Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe 3, 399-407 (2008).
34. Bagalkot, V. et al. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett. 7, 3065-70 (2007).
35. Creighton, J. A., Blatchford C. G. & Albrecht, M. G. Plasma resonance enhancement of Raman scattering by pyridine adsorbed on silver or gold sol particles of size comparable to the excitation wavelength. J. Chem. Soc., Faraday Trans. 75, 790-798 (1979).
36. Desjardins, M. & Griffiths, G. Phagocytosis: latex leads the way. Current opinion in cell biology 15, 498-503 (2003).
37. Jarlier, V. & Nikaido, H. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett. 123, 11-8 (1994).
38. Isefuku, S., Joyner, C. J. & Simpson, A. H. Toxic effect of rifampicin on human osteoblast-like cells. J Orthop Res. 19, 950-4 (2001).
39. Girling, D. J. The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide. Tubercle. 59, 13-32 (1978).
40. Santhosh, S., Sini, T. K., Anandan, R. & Mathew, P. T. Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats. Eur J Pharmacol. 572, 69-73 (2007).
41. He, X., Gao, L. & Ma, N. One-step instant synthesis of protein-conjugated quantum dots at room temperature. Sci Rep. 3, 2825 (2013).
42. Li, H. & Qian, Z. M. Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev. 22, 225-50 (2002).
43. Qian, Z. M., Li, H., Sun, H. & Ho, K. Targeted drug delivery via the transferring receptor-mediated endocytosis pathway. Pharmacol Rev. 54, 561-87 (2002).
44. Ray, A. & Dittel, B. N. Isolation of mouse peritoneal cavity cells. J Vis Exp. 35, 1488 (2010).
45. Inaba, K., Swiggard, W. J., Steinman, R. M., Romani, N. & Schuler, G. Isolation of dendritic cells. Curr Protoc Immunol. 25, 371-375 (2001).
46. Fenech, M. Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death. Mutation research 600, 58-66 (2006).